Chinese biotechnology company JW Therapeutics is planning an initial public offering (IPO) in Hong Kong, joining a rush of pharmaceutical and biotech IPOs in the city.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
